Bumper Offer - Urjas oil Just @ Rs. 1
NAC SR 75 Tablet is a commercial drug that is prescribed in the form of Tablet. It is primarily used for the treatment of Muscle Pain, Toothache, Rheumatic Pain. The alternative uses of NAC SR 75 Tablet have also been explained below.
The correct dosage of NAC SR 75 Tablet depends on the patient's age, gender, and medical history. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. For detailed information on this, read through the dosage section.
While these are the most often observed NAC SR 75 Tablet side effects, there are can be others also. These have been listed below. Normally, these side effects of NAC SR 75 Tablet are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
It is also important to note that NAC SR 75 Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. In addition, NAC SR 75 Tablet's effects on the liver, heart and kidney are discussed below in the NAC SR 75 Tablet related warnings section.
NAC SR 75 Tablet is contraindicated in people with pre-existing medical conditions like Stomach Infection, Skin Rash, Stroke as it can result in adverse effects. Some other conditions that can be affected by NAC SR 75 Tablet are listed in the contraindications section below.
Additionally, NAC SR 75 Tablet may also adversely react with other medicines. See below for a complete list.
In addition to these precautions, you may also note that NAC SR 75 Tablet is safe while driving, and is is addictive in nature.
NAC SR 75 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when NAC SR 75 Tablet is used -
Severe
Moderate
Mild
Is the use of NAC SR 75 Tablet safe for pregnant women?
Nac shows severe side effect on pregnant women. For this reason, pregnant women should only take it after taking medical advice.
Is the use of NAC SR 75 Tablet safe during breastfeeding?
Side effects of Nac on breastfeeding women are very mild.
What is the effect of NAC SR 75 Tablet on the Kidneys?
Effects of Nac on kidney can be severe. It is not safe to use it without doctor's advice.
What is the effect of NAC SR 75 Tablet on the Liver?
Nac can cause side effects that could harm the liver. So medical advice before taking it is necessary.
What is the effect of NAC SR 75 Tablet on the Heart?
You may experience side effects on your heart after taking Nac. If this happens, then discontinue its use. Consult your medical practitioner, and do as he/she suggests.
NAC SR 75 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take NAC SR 75 Tablet unless your doctor advises you to do so -
Is this NAC SR 75 Tablet habit forming or addictive?
No, you will not get addicted to NAC SR 75 Tablet.
Is it safe to drive or operate heavy machinery when consuming?
NAC SR 75 Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but take NAC SR 75 Tablet only as per medical advice.
Is it able to treat mental disorders?
No, NAC SR 75 Tablet cannot treat any kind of mental disorder.
Interaction between Food and NAC SR 75 Tablet
There isn't any research available on the side effects of taking NAC SR 75 Tablet with food.
Interaction between Alcohol and NAC SR 75 Tablet
Consult your doctor before consuming alcohol while taking NAC SR 75 Tablet as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)
Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)
